Close Menu

NEW YORK (GenomeWeb) – SkylineDx said today that it is collaborating with the Mayo Clinic to develop new diagnostic tests to improve clinical decision-making for melanoma patients.

The company said that it is lending its expertise in informatics to help optimize and further develop an algorithm — originally discovered and developed by Mayo Clinic dermatologist Alexander Meves — that identifies risk factors associated with metastasis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.